Two-sided intensity: both new counterparties arriving and existing ones enlarging in the same recent period
The model's full reasoning — Q4 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that in recent period company's business intensified from BOTH directions at once: (1) NEW paying counterparties actually arrived: fresh customers, accounts, partners, or programs that actually signed, ordered, or began transacting in recent period, described as real events rather than pipeline; AND (2) EXISTING counterparties enlarged what they take: accounts or relationships company already had that visibly stepped up their orders, scope, volumes, sites, usage, or commitments in same recent period, by counterparty's own choice rather than price increases alone — with management presenting this two-sided build as observed current pattern meaningful to future? We need examine transcript. Company has HETLIOZ and Fanapt. HETLIOZ: strong interest with new patient prescriptions especially sighted patients with Non-24. However increased payer denial led to net decline of Non-24 patients in treatment. Launched HETLIOZ for SMS indication. More than 50 patients with SMS currently on treatment and more awaiting payer approval. Working with advocacy. So new paying counterparties? SMS patients on treatment? Yes, more than 50 patients currently on treatment, real event. Also maybe new patient prescriptions for Non-24? But net decline. Existing counterparties enlarged? Payer challenges, access. For Fanapt? Phase III bipolar disorder >50% enrolled, not commercial. No mention of existing accounts increasing orders. HETLIOZ net product sales growth driven by net price favorability, partially offset by lower unit sales. So not volume. Fanapt sales growth 9% full year but fourth quarter flat, prescriptions down 2% QoQ. No mention existing customers expanding. Question asks "recent period" likely Q4 2021. Did management describe both new customer arrivals and existing customers increasing? New: SMS launch, >50 patients on treatment. Existing: not really. HETLIOZ Non-24 net decline due to denials. No expansion of existing relationships. Could "more patients awaiting payer approval" be pipeline? Not arrived. Also payer access improvements? That's not counterparties enlarging what they take. No. Answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| SNV | Synovus Financial Corp. | Q1 2024 | 2024-04-18 | B |
| PBR | Petróleo Brasileiro S.A. - Petrobras | Q4 2023 | 2024-03-08 | D |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| VIPS | Vipshop Holdings Limited | Q2 2023 | 2023-08-18 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| PERI | Perion Network Ltd. | Q2 2023 | 2023-08-02 | A |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HIW | Highwoods Properties, Inc. | Q4 2022 | 2023-02-08 | B |
| CNA | CNA Financial Corporation | Q4 2022 | 2023-02-06 | B |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| TCBI | Texas Capital Bancshares, Inc. | Q2 2021 | 2021-07-21 | F |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| OGE | OGE Energy Corp. | Q3 2018 | 2018-11-08 | A |
| ROP | Roper Technologies, Inc. | Q2 2018 | 2018-07-26 | A |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| DLHC | DLH Holdings Corp. | Q1 2018 | 2018-02-06 | C+ |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| SBFG | SB Financial Group, Inc. | Q3 2017 | 2017-10-20 | A |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ICFI | ICF International, Inc. | Q1 2017 | 2017-05-06 | B+ |
| ATO | Atmos Energy Corporation | Q1 2017 | 2017-02-08 | A |
| EFSC | Enterprise Financial Services Corp | Q4 2016 | 2017-01-24 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| BCH | Banco de Chile | Q3 2016 | 2016-10-30 | B+ |
| ULBI | Ultralife Corporation | Q3 2016 | 2016-10-29 | C+ |
| MAT | Mattel, Inc. | Q3 2016 | 2016-10-19 | C |
| VRNS | Varonis Systems, Inc. | Q2 2016 | 2016-08-09 | B+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
PFIE · Q1 2023 → YESThe question is about whether management describes intensification from BOTH new paying counterparties AND existing ones enlarging what they take, in the recent period, as observed facts. YES Management describes both new arrivals ("new customers," "new opportunities," "several project opportunities," "notable customers" including specific ones like Equitrans Midstream and Enterprise Products) and existing-customer expansion ("repeat orders," "repeat business," "repeat orders from one of the United States’ largest producers," " 85,000 burner management solutions," "large uptick... on retrofits") as already-completed facts in the recent period. They present the combination—widening the customer base while deepening relationships—as the current observed pattern driving the business forward.
EPAM · Q4 2017 → YESThe question is about whether management describes that in the recent period the company's business intensified from BOTH directions at once: new paying counterparties arrived AND existing ones enlarg...YES Management describes both sides occurring together in the recent period: new engagements with clients (including specific examples like the European multinational and Global Health Services Company that started less than 12 months ago) alongside growth within the top 20 existing accounts (more than 18% year-over-year) and even stronger growth outside those 20 (34%). They frame this as an observed pattern of widening and deepening the business now, with continued diversification and expansion across both new and existing relationships.
UNH · Q4 2017 → YESThe question is about whether management describes that in the recent period the company's business intensified from BOTH directions at once: new paying counterparties arrived AND existing ones enlarg...YES Management describes both new paying counterparties (e.g., new states like West Virginia, hospitals using Rally, healthcare transformation alliance with 10 companies, acquisitions like Banmedica and DaVita) and existing ones enlarging (e.g., serving nearly 1 million more seniors in Medicare, 465,000 more in commercial group, strong growth with existing client base for PBM, doubled Rally IDs, 7% same-store growth for SCA, highest Q4 script growth).